Research Article
[Retracted] LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation
Table 1
Clinical characteristics of patients.
| | Characteristics | Median (25th-75th percentile) or no. (%) |
| | Sex | | | Male | 142 (91.6) | | Female | 13 (8.3) | | Age (years) | 50 (42-58) | | Child-Pugh class | | | A | 47 (30.3) | | B | 87 (56.1) | | C | 21 (13.5) | | MELD score | 11 (8-18) | | Tumor number | | | <3 | 82 (52.9) | | ≥3 | 73 (47.1) | | Largest tumor size (mm) | 44 (25-80) | | Edmondson grading | | | I-II | 111 (71.6) | | III-IV | 44 (28.4) | | AFP (ng/ml) | 117.24 (10.12-2614.33) | | BMI (kg/m2) | 22.15 (20.42-24.09) | | Macrovascular invasion | | | Yes | 121 (78.1) | | No | 34 (21.9) | | Microvascular invasion | | | Yes | 115 (74.2) | | No | 40 (25.8) | | Pre-LT treatment | | | Surgical resection | 30 (19.3) | | TACE | 174 (47.7) | | RFA | 29 (18.7) | | Milan criteria | | | Yes | 49 (31.6) | | No | 106 (68.4) | | Hangzhou criteria | | | Yes | 110 (71.0) | | No | 45 (29.0) | | HCC recurrence | 65 (41.9) | | Follow-up (months) | 40 (22-54) | | GGT (U/l) | 111 (51-201) | | ALT (U/l) | 38 (25-58) | | LDH (U/l) | 208 (181-268) |
|
|
